Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/jcm4030441 http://scihub22266oqcxt.onion/10.3390/jcm4030441 C4470138!4470138!26239248     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Med 2015 ; 4 (3): 441-59 Nephropedia Template TP {{tp|p=26239248|t=2015. Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients |pdf=|usr=}}{{26239248}} gab.com Text Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients JO: J Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=26239248 #FOAvip The objectives of this review were to discuss standard and investigational treatment strategies for adolescent and young adult with acute myeloid leukemia, excluding acute promyelocytic leukemia. Acute myeloid leukemia (AML) in adolescent and young adult patients (AYAs) may need a different type of therapy than those currently used in children and older patients. As soon as AML is diagnosed, AYA patient should be offered to participate in well-designed clinical trials. The standard treatment approach for AYAs with AML is remission induction chemotherapy with an anthracycline/cytarabine combination, followed by either consolidation chemotherapy or stem cell transplantation, depending on the ability of the patient to tolerate intensive treatment and cytogenetic features. Presently, continuing progress of novel drugs targeting specific pathways in acute leukemia may bring AML treatment into a new era. Twit Text FOAVip Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients ????J Clin Med http://www.kidney.de/pget.php?&tw=1&pmid=26239248 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26239248 #FOAvip English Wikipedia <ref>{{Cite pmid|26239248}}</ref> Treatment of Acute Myeloid Leukemia in Adolescent and Young Adult Patients #MMPMID26239248 Cengiz Seval G; Ozcan M J Clin Med 2015[Mar]; 4 (3): 441-59 PMID26239248show ga The objectives of this review were to discuss standard and investigational treatment strategies for adolescent and young adult with acute myeloid leukemia, excluding acute promyelocytic leukemia. Acute myeloid leukemia (AML) in adolescent and young adult patients (AYAs) may need a different type of therapy than those currently used in children and older patients. As soon as AML is diagnosed, AYA patient should be offered to participate in well-designed clinical trials. The standard treatment approach for AYAs with AML is remission induction chemotherapy with an anthracycline/cytarabine combination, followed by either consolidation chemotherapy or stem cell transplantation, depending on the ability of the patient to tolerate intensive treatment and cytogenetic features. Presently, continuing progress of novel drugs targeting specific pathways in acute leukemia may bring AML treatment into a new era. äTreatment of Acute Myeloid Leukemia in Adolescent and Young Adult Pati(epmc).pdf DeepDyve Pubget Overpricing